Yuman Fong, MD
Yuman Fong, MD, Chair of City of Hope’s Department of Surgery and Director of its Center for Surgical Innovation, has been named a recipient of the 2022 Flance-Karl Award by the American Surgical Association (ASA). The award is given annually to one surgeon in the United States who has made seminal contributions in translational research that have applications to clinical surgery. It is one of the world’s most prestigious recognitions in scientific achievement.
A pioneer both in the operating room and in the laboratory, Dr. Fong is an internationally recognized expert in cancers of the liver, pancreas, gallbladder, and bile ducts. He has led the research effort to employ genetically modified viruses to destroy cancer cells and to harness the human immune system for the treatment of cancer. He has also helped to design and deploy many surgical tools and techniques, including robotic technologies, for the surgical treatment of cancer. Both an author and innovator, Dr. Fong has written and edited more than 1,000 scholarly articles and 22 textbooks.
“My work is focused on advancing cancer therapies for the benefit of patients,” Dr. Fong commented. “This is a great honor to be recognized among such an extraordinary group of surgeons who have received this award in previous years. I am so grateful to City of Hope for providing an environment that has allowed me to invent and to mentor young surgeons in research. I am particularly happy because this recognition puts City of Hope surgical research in the national spotlight.”
